Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Pathology and Oncology Research

• Publication date

  2019-03-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12253-019-00644-xPMID 30919275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent.

  2017cited by this paper
• Mucin secreting cells in the stomach and colon are altered by combination antiretroviral treatment in an obese rat model.

  2017cited by this paper
• MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

  2014cited by this paper
• Emerging evidence on the pathobiology of mucositis

  2013cited by this paper
• Emerging evidence on the pathobiology of mucositis

  2013cited by this paper
• IL-22 Mediates Goblet Cell Hyperplasia and Worm Expulsion in Intestinal Helminth Infection

  2013cited by this paper
• Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system.

  2013cited by this paper
• Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

  2012cited by this paper
• The enteric nervous system and neurogastroenterology

  2012cited by this paper
• Anti-Inflammatory Cytokines: Important Immunoregulatory Factors Contributing to Chemotherapy-Induced Gastrointestinal Mucositis

  2012cited by this paper
• Enteric Nervous System: The Brain-in-the-Gut

  2011cited by this paper
• Irinotecan-induced mucositis is associated with changes in intestinal mucins

  2009cited by this paper
• Irinotecan‐induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile

  2009cited by this paper
• Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis

  2009cited by this paper
• Histology and Mucin Histochemistry of The Digestive Tract of Yellow Catfish, Pelteobagrus fulvidraco

  2009cited by this paper
• Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis

  2008cited by this paper
• Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs

  2008cited by this paper
• Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs.

  2008cited by this paper
• Nitrosation of N-methylhydroxylamine by nitroprusside. A kinetic and mechanistic study.

  2008cited by this paper
• Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis

  2008cited by this paper
• Updated clinical practice guidelines for the prevention and treatment of mucositis

  2007cited by this paper
• Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.

  2007cited by this paper
• Methotrexate‐induced mucositis in mucin 2‐deficient mice

  2007cited by this paper
• Methotrexate-induced mucositis in mucin 2-deficient mice.

  2006cited by this paper
• Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

  2006cited by this paper
• Irinotecan changes gene expression in the small intestine of the rat with breast cancer

  2006cited by this paper
• Cytotoxic chemotherapy upregulates pro‐apoptotic Bax and Bak in the small intestine of rats and humans

  2005cited by this paper
• Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor‐bearing DA rats

  2005cited by this paper
• Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

  2004cited by this paper
• Gastrointestinal mucositis: a new biological model

  2004cited by this paper
• Perspectives on cancer therapy‐induced mucosal injury

  2004cited by this paper
• Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer

  2003cited by this paper
• Understanding and managing chemotherapy-induced diarrhea.

  2003cited by this paper
• The burdens of cancer therapy

  2003cited by this paper
• The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer

  2002cited by this paper
• Effect of Interleukin-11 on Ameliorating Intestinal Damage After Methotrexate Treatment of Breast Cancer in Rats

  2002cited by this paper
• Microbial modulation of innate defense: goblet cells and the intestinal mucus layer.

  2001cited by this paper
• Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon

  2000cited by this paper
• Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

  2000cited by this paper
• Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats.

  2000cited by this paper
• II. The intestine as a sensory organ: neural, endocrine, and immune responses.

  1999influential reference
• Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon.

  1998influential reference
• Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon.

  1998cited by this paper
• Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats

  1998cited by this paper
• Recommended guidelines for the treatment of chemotherapy-induced diarrhea.

  1998cited by this paper
• Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting.

  1998cited by this paper
• Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.

  1997cited by this paper
• Effect of high-dose chemotherapy on intestinal permeability in humans.

  1997cited by this paper
• Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway.

  1997cited by this paper
• Expression pattern of S100 calcium‐binding proteins in human tumors

  1996cited by this paper
• Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.

  1996cited by this paper
• The effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of mucin glycoproteins.

  1993cited by this paper
• Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy.

  1992cited by this paper
• The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues.

  1990cited by this paper
• Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.

  1989influential reference
• Regulation of intestinal goblet cell secretion. IV. Electrical field stimulation in vitro.

  1984cited by this paper
• Mechanism of rapid mucus secretion in goblet cells stimulated by acetylcholine

  1980cited by this paper
• Anaphylactic release of intestinal goblet cell mucus.

  1980cited by this paper

• Dunhuang Gancao Fuling Xingren decoction and its components alleviate CPT-11 induced intestinal mucositis by regulating gut microbiota related innate immunity and inflammatory response in Drosophila and mice

  2026cites this paper
• Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites

  2025cites this paper
• Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach

  2025cites this paper
• Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations

  2025cites this paper
• Comprehensive pharmacovigilance of phytoalkaloid chemotherapeutics: Signal detection and time-to-onset analysis based on FAERS

  2025cites this paper
• Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol

  2024cites this paper
• Chemotherapy‐Induced Neuropathy Affecting the Gastrointestinal Tract

  2024cites this paper
• Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation.

  2023cites this paper
• Green tea extract prevents CPT-11-induced diarrhea by regulating the gut microbiota

  2023cites this paper
• Gallic Acid Protects Against Methotrexate - Induced Intestinal Mucositis; Oxidative Stress, Histopathology and Inflammatory Status

  2023cites this paper
• Experimental Chemotherapy-Induced Mucositis: A Scoping Review Guiding the Design of Suitable Preclinical Models

  2022cites this paper
• Mechanisms of Chemotherapy-Induced Neurotoxicity

  2022cites this paper
• Decreased Tissue Omega-6/Omega-3 Fatty Acid Ratio Prevents Chemotherapy-Induced Gastrointestinal Toxicity Associated with Alterations of Gut Microbiome

  2022cites this paper
• Successful pre-clinical management of irinotecan-debilitated animals: A protein-based accessory phytomedicine.

  2022cites this paper
• Effects of coronavirus disease 19 on the gastrointestinal tract and the potential impact on gastrointestinal toxicities during cancer treatment

  2022cites this paper
• Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade.

  2022cites this paper
• Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis

  2022cites this paper
• Maintenance of Enteral ACE2 Prevents Diabetic Retinopathy in Type 1 Diabetes

  2022cites this paper
• The expression of P2Y6 receptor promotes the quality of mucus in colitic mice

  2021cites this paper
• Irinotecan-induced intestinal mucositis in mice: a histopathological study

  2020cites this paper
• Impact of chemotherapy-induced enteric nervous system toxicity on gastrointestinal mucositis.

  2020cites this paper
• Irinotecan: 25 years of cancer treatment.

  2019cites this paper